Hh pathway mutations like PTCH1 are known to be oncogenic in basal cell carcinoma and have been successfully targeted with small molecule inhibitors of smoothened (SMO) like vismodegib [14]. The gene discussed is SMO; the disease is basal cell carcinoma.